Browsing by Author Prue, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2016CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responsesBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho Lo, Tsun; Horvath, Lisa; Joshua, Douglas; Papadimitrious, Michael Stephen; Silveira, Pablo; Van Kooten Losio, Nicolas; Verma, Nirupama; Anguille, Sebastien; Barnard, Ross; et al, Various; Hsu, Jennifer; Mahler, Stephen; Munster, David; Nagasakid, Tomoko; Prue, R; Turtle, Cameron; Vukovic, Peter; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteCMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses, OncoImmunology, vol.5, 6, 2016,pp 1-12
2013A flow cytometry based assay for the enumeration of regulatory T cells in whole bloodHart, Derek; Hardy, Melinda; Prue, R; Rossetti, T; Vari, F; Concord Clinical School: ANZAC Research InstituteA flow cytometry based assay for the enumeration of regulatory T cells in whole blood, Journal of Immunological Methods, vol.390, 1-2, 2013,pp 121-126
2015A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancerHart, Derek; Coleman, Robert; D'Rozario, Rachael; et al, Various; Hardy, Melinda; Prue, R; Radford, Kristen; Rossetti, T; Tong, Hui; Tracey, Christopher; Vari, F; Waterhouse, Nigel; Concord Clinical School: ANZAC Research InstituteA phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer, Journal of Immunotherapy, vol.38, 2, 2015,pp 71-76
2008Practical blood dendritic cell vaccination for immunotherapy of multiple myelomaHart, Derek; Grey, P; Hsu, J; Mahler, Stephen; Munster, David J; Prue, R; Rossetti, T; Turtle, C; Vari, F; Concord Clinical School: ANZAC Research InstitutePractical blood dendritic cell vaccination for immunotherapy of multiple myeloma, British Journal of Haematology, vol.143, 3,pp 374-377